A 48-Month Study to Evaluate Long-Term Effectiveness of Elocta on Joint Health
Condition: Hemophilia A · Sponsor: Swedish Orphan Biovitrum
About this study
This is a 48-month observational, prospective, multicentre study. The overall aim of the study is to evaluate the long-term effectiveness of Elocta treatment on joint health in patients treated prophylactically with Elocta in a real-world setting.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (53)
| University Hospital Brno | Brno, Czechia | — |
| University Hospital Ostrava | Ostrava, Czechia | — |
| Dept. of Pediatric Haematology and Oncology, University Hospital Motol | Prague, Czechia | — |
| Lastehaigla, Tallinn (Tallinn Children´s Hospital) | Tallinn, Estonia | — |
| The North Estonia Medical Centre Hematoloogiakeskus, Regionalhaigla | Tallinn, Estonia | — |
| Helsinki University Central Hospital, New Children Hospital | Helsinki, Finland | — |
| Turku University Central Hospital, Paediatric and adolescent haematology and oncology clinic | Turku, Finland | — |
| Charité-Universitätsmedizin Berlin Campus Virchow Klinikum | Berlin, Germany | — |
| Universitätsklinikum Bonn AöR, Institut für Experimentelle Hämatologie und Transfusionsmedizin | Bonn, Germany | — |
| Hämostaseologie/Hämophiliezentrum, Medizinische Klinik 2 Institut für Transfusionsmedizin, Universitätsklinikum | Frankfurt, Germany | — |
| Universitätsklinikum Frankfurt - Klinik für Kinder- und Jugendmedizin | Frankfurt, Germany | — |
| Universitätsklinikum Hamburg-Eppendorf (UKE) | Hamburg, Germany | — |
+ 41 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04293523